Voyager Therapeutics Inc
(92915B106)
ファンドの報告 Voyager Therapeutics Inc 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Casdin Capital LLC | 1,128,075 | $30,706,202k | Jun 30, 2019 | Aug 13, 2019 | |
| Partner Fund Management LP | 2,117,388 | $57,635k | Jun 30, 2019 | Aug 14, 2019 | |
| Armistice Capital LLC | 936,000 | $25,478k | Jun 30, 2019 | Aug 14, 2019 | |
| Farallon Capital Management LLC | 750,000 | $20,415k | Jun 30, 2019 | Aug 14, 2019 | |
| Highline Capital Management LP | 296,773 | $8,078k | Jun 30, 2019 | Aug 14, 2019 | |
| The Fiduciary Group LLC | 155,343 | $4,228k | Jun 30, 2019 | Aug 14, 2019 | |
| HHR Asset Management LLC | 92,131 | $2,508k | Jun 30, 2019 | Aug 14, 2019 | |
| QS Investors LLC | 71,800 | $1,955k | Jun 30, 2019 | Aug 14, 2019 | |
| Altrinsic Global Advisors LLC | 50,000 | $1,361k | Jun 30, 2019 | Aug 14, 2019 | |
| EAM Global Investors LLC | 49,878 | $1,358k | Jun 30, 2019 | Aug 14, 2019 | |
| Tocqueville Asset Management LP | 22,825 | $621k | Jun 30, 2019 | Jul 31, 2019 |